申请人:E.I. DU PONT DE NEMOURS AND COMPANY
公开号:EP0005357A1
公开(公告)日:1979-11-14
N-(Benzothienopyrazol)-amides of formula
[in which R, is methyl or ethyl; R2 is cyclohexyl, phenyl, 3-pyridyl. C2-5 haloalkyl, C3-5 alkoxyalkyl or
(wherein R3 and R4 are hydrogen, methyl or ethyl; and R5 is hydrogen or C1-5 alkyl): and R6 is hydrogen, chlorine, fluorine, methyl, 6,7-methylenedioxy, 6,7-dimethoxy, 6,7-diacetoxy or -NR7RB (wherein R7 and R8 are hydrogen, methyl or ethyl; with the provisos that (a) when R2 is cyclohexyl, then R6 is hydrogen. methyl or ethyl, (b) when R2 is phenyl, then R6 is hydrogen, and (c) when R2 is 3-pyridyl, then R6 is hydrogen or fluorine] and pharmaceutically acceptable acid addition salts thereof. The compounds exhibit a strong antiviral activity. Pharmaceutical compositions containing the compounds are described and exemplified.
式中的 N-(苯并噻吩吡唑)-酰胺
[其中 R 是甲基或乙基;R2 是环己基、苯基、3-吡啶基。C2-5卤代烷基、C3-5烷氧基烷基或
(其中 R3 和 R4 为氢、甲基或乙基;R5 为氢或 C1-5 烷基):且 R6 为氢、氯、氟、甲基、6,7-亚甲基二氧基、6,7-二甲氧基、6,7-二乙酰氧基或 -NR7RB (其中 R7 和 R8 为氢、甲基或乙基;但书为 (a) 当 R2 为环己基时,则 R6 为氢。(b) 当 R2 为苯基时,则 R6 为氢;以及 (c) 当 R2 为 3-吡啶基时,则 R6 为氢或氟] 及其药学上可接受的酸加成盐。这些化合物具有很强的抗病毒活性。本文描述并举例说明了含有这些化合物的药物组合物。